Biomaterials

Core Idea

Biomaterials are materials designed to interface with biological systems for medical purposes — implants, scaffolds, drug delivery vehicles, and diagnostic sensors. The central requirement is biocompatibility: the material must perform its function without eliciting harmful immune responses, toxic leaching, or thrombosis. Biomaterials span all material classes: metals (Ti-6Al-4V for orthopedic implants), ceramics (hydroxyapatite for bone repair), polymers (PLGA for resorbable sutures and drug delivery), and composites (carbon fiber-reinforced PEEK for spinal implants). The material's surface chemistry determines the biological response — protein adsorption within seconds of implantation triggers the cascade of events (inflammation, foreign body reaction, integration or encapsulation) that determines success or failure.

Explainer

Biomaterials occupy a unique position in materials chemistry because their performance is judged not just by physical and chemical properties but by their interaction with living tissue. A hip implant must bear millions of load cycles, resist corrosion by body fluids, and avoid triggering chronic inflammation — all simultaneously, for decades. This multi-requirement challenge draws on every branch of materials science.

Biocompatibility is not a single property but a system-level outcome of material-tissue interaction. When any material is implanted, proteins adsorb within seconds, cells arrive within minutes, and the inflammatory cascade progresses over days. The adsorbed protein layer — not the material surface itself — is what cells actually interact with. A hydrophobic surface adsorbs proteins in denatured conformations that present cell-binding sites for macrophages and inflammatory cells; a hydrophilic surface (PEG, zwitterionic polymers) resists protein adsorption and can reduce the foreign body response. Surface chemistry is therefore the primary handle for controlling biological response.

Metals for implants require the combination of high strength, corrosion resistance, and biocompatibility. Titanium alloys (Ti-6Al-4V) and cobalt-chromium alloys dominate orthopedic applications. Stainless steel (316L) is used for temporary implants (fracture fixation plates). Shape-memory alloys (NiTi, Nitinol) are used for stents and orthodontic wires. In each case, the passive oxide layer (TiO2, Cr2O3) provides the corrosion resistance and biocompatibility; disruption of the oxide by wear or fretting can release toxic ions and trigger adverse reactions.

Biodegradable polymers (PLGA, PCL, PGA) are designed to perform a temporary function and then disappear, eliminated through natural metabolic pathways. Applications include resorbable sutures, drug delivery particles (where the polymer matrix controls release rate), and tissue engineering scaffolds (where the scaffold provides temporary mechanical support while new tissue grows, then degrades as the tissue matures). The degradation rate must match the tissue regeneration rate — too fast and the scaffold fails before tissue forms; too slow and it interferes with tissue remodeling. Tuning degradation through copolymer composition, molecular weight, and porosity is a central materials chemistry problem in tissue engineering.

Ceramic biomaterials include bioinert materials (alumina, zirconia for wear-resistant bearing surfaces in hip joints) and bioactive materials (hydroxyapatite Ca10(PO4)6(OH)2, which chemically bonds to bone). Hydroxyapatite is the mineral component of natural bone, so synthetic HA coatings on metallic implants promote osseointegration by providing a familiar surface for osteoblast adhesion and mineralization. Bioactive glasses (developed by Larry Hench in 1969) dissolve slowly in body fluid, releasing Ca²+ and Si⁴+ ions that stimulate osteoblast gene expression and bone formation — the material actively promotes healing rather than merely being tolerated.